NCT03338972 2023-09-08Immunotherapy With BCMA CAR-T Cells in Treating Patients With BCMA Positive Relapsed or Refractory Multiple MyelomaFred Hutchinson Cancer CenterPhase 1 Completed28 enrolled 18 charts
NCT02761915 2021-08-17A Phase I Trial of Anti-GD2 T-cells (1RG-CART)Cancer Research UKPhase 1 Completed17 enrolled 17 charts